When all else fails, researchers find new therapy for melanoma

This year, more than 104,000 people will be told they have melanoma, and more than 8,000 will die from the disease. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.